Holen Sie sich die Stockscreener-App
230.42
3.22%
7.19
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$223.23
Offen:
$224.11
24-Stunden-Volumen:
3.88M
Relative Volume:
0.93
Marktkapitalisierung:
$162.76B
Einnahmen:
$24.27B
Nettoeinkommen (Verlust:
$3.50B
KGV:
47.42
EPS:
4.8589
Netto-Cashflow:
$5.02B
1W Leistung:
+0.86%
1M Leistung:
+9.12%
6M Leistung:
+13.72%
1J Leistung:
-1.67%
1-Tages-Spanne:
$223.27
$230.48
1-Wochen-Bereich:
$223.19
$230.48
52-Wochen-Spanne:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Vergleichen Sie DHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher Corporation (NYSE:DHR) Declares $0.32 Quarterly Dividend - MarketBeat
WINTON GROUP Ltd Sells 8,528 Shares of Danaher Corporation $DHR - MarketBeat
Dymon Asia Capital Singapore PTE. LTD. Takes $1.98 Million Position in Danaher Corporation $DHR - MarketBeat
Federated Hermes Inc. Sells 64,794 Shares of Danaher Corporation $DHR - MarketBeat
Daiwa Securities Group Inc. Buys 10,126 Shares of Danaher Corporation $DHR - MarketBeat
Axa S.A. Purchases 71,060 Shares of Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To Watch NowDecember 6th - MarketBeat
Microscopy Devices Market Is Booming Worldwide |Danaher - openPR.com
Biotech Stocks To Add to Your WatchlistDecember 5th - MarketBeat
Danaher declares $0.32 per share quarterly dividend - Investing.com
Danaher (NYSE: DHR) declares $0.32 dividend, paid Jan. 30 to holders on Dec. 26 - Stock Titan
Danaher Announces Quarterly Dividend - Yahoo Finance
A year of science in motion - Danaher Corporation
Danaher Corporation $DHR Shares Sold by State Street Corp - MarketBeat
Goldman Sachs Initiates Coverage on Danaher (DHR) with Buy Ratin - GuruFocus
Leica Biosystems Expands Clinical Digital Pathology Portfolio with Multiple Launches at DPAI 2025 - PR Newswire
Goldman Sachs initiates Danaher stock with Buy rating on bioprocessing strength - Investing.com
Vega Investment Solutions Has $1.37 Million Holdings in Danaher Corporation $DHR - MarketBeat
SVB Wealth LLC Makes New $4.73 Million Investment in Danaher Corporation $DHR - MarketBeat
Natixis Increases Holdings in Danaher Corporation $DHR - MarketBeat
Rivulet Capital LLC Has $114.33 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Temasek Holdings Private Ltd Grows Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Holdings Raised by Thematics Asset Management - MarketBeat
Ossiam Has $28.59 Million Stake in Danaher Corporation $DHR - MarketBeat
Jump Financial LLC Decreases Position in Danaher Corporation $DHR - MarketBeat
Top Biotech Stocks To ConsiderDecember 4th - MarketBeat
Best Biotech Stocks To ConsiderDecember 7th - MarketBeat
Danaher Corporation $DHR Shares Purchased by Guggenheim Capital LLC - MarketBeat
California Public Employees Retirement System Has $270.06 Million Position in Danaher Corporation $DHR - MarketBeat
Dnca Finance Sells 5,500 Shares of Danaher Corporation $DHR - MarketBeat
Cresset Asset Management LLC Has $6.05 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Marshall Wace LLP Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Kennedy Capital Management LLC - MarketBeat
Invesco Ltd. Sells 1,625,047 Shares of Danaher Corporation $DHR - MarketBeat
Brown Advisory Inc. Reduces Holdings in Danaher Corporation $DHR - MarketBeat
How New Signals Are Gradually Shifting the Narrative for Danaher - Yahoo Finance
Danaher Corporation $DHR Shares Sold by Amundi - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Danaher Corporation (DHR) And Encourages Investors to Connect - ACCESS Newswire
Danaher Corporation (DHR): A Bull Case Theory - Finviz
Danaher (DHR) Valuation Check After Analyst Upgrade and 2026 Earnings Recovery Narrative - simplywall.st
Pragma Gestao DE Patrimonio Ltd. Invests $5.20 Million in Danaher Corporation $DHR - MarketBeat
Baird Financial Group Inc. Buys 405,785 Shares of Danaher Corporation $DHR - MarketBeat
Annandale Capital LLC Takes Position in Danaher Corporation $DHR - MarketBeat
What downside risks could hit Danaher Corporation stock2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser
Jim Cramer Says "Danaher's Been Acting Much Better" - Finviz
Jim Cramer Says “Danaher’s Been Acting Much Better” - Insider Monkey
Brady Corporation elects Board of Directors and declares regular dividend to shareholders - Benzinga
Danaher Corporation $DHR Position Boosted by Van Hulzen Asset Management LLC - MarketBeat
Quantbot Technologies LP Has $10.40 Million Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by M&T Bank Corp - MarketBeat
Northwestern Mutual Wealth Management Co. Sells 7,279 Shares of Danaher Corporation $DHR - MarketBeat
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):